Bempedoic acid inhibits ATP citrate lyase (ACL), an enzyme which converts Citrate to Acetyl CoA . After this step, the pathway is same i.e. Acetyl CoA to HMG CoA and mevalonate (targeted by statins) and cholesterol. My questions are:-
1) If the downstream pathway is same, why this compound is considered as an effective option?
2) We do have additional LDL lowering option (if statins are not effective) e.g. ranging from Ezetimibe to PCSK9 inhibitors. Then what is the added advantage of Bempedoic acid over these options?
3) Are there any special patient groups which respond more to this compound?